334 related articles for article (PubMed ID: 32248367)
1. Missing heritability in Parkinson's disease: the emerging role of non-coding genetic variation.
Ohnmacht J; May P; Sinkkonen L; Krüger R
J Neural Transm (Vienna); 2020 May; 127(5):729-748. PubMed ID: 32248367
[TBL] [Abstract][Full Text] [Related]
2. The Role of Structural Variants in the Genetic Architecture of Parkinson's Disease.
Miano-Burkhardt A; Alvarez Jerez P; Daida K; Bandres Ciga S; Billingsley KJ
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732020
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from India.
Kukkle PL; Geetha TS; Chaudhary R; Sathirapongsasuti JF; Goyal V; Kandadai RM; Kumar H; Borgohain R; Mukherjee A; Oliver M; Sunil M; Mootor MFE; Kapil S; Mandloi N; Wadia PM; Yadav R; Desai S; Kumar N; Biswas A; Pal PK; Muthane UB; Das SK; Sakthivel Murugan SM; Peterson AS; Stawiski EW; Seshagiri S; Gupta R; Ramprasad VL; Prai PRAOI
Adv Biol (Weinh); 2022 Nov; 6(11):e2101326. PubMed ID: 35810474
[TBL] [Abstract][Full Text] [Related]
4. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease.
Bandres-Ciga S; Saez-Atienzar S; Bonet-Ponce L; Billingsley K; Vitale D; Blauwendraat C; Gibbs JR; Pihlstrøm L; Gan-Or Z; ; Cookson MR; Nalls MA; Singleton AB
Mov Disord; 2019 Apr; 34(4):460-468. PubMed ID: 30675927
[TBL] [Abstract][Full Text] [Related]
5. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
[TBL] [Abstract][Full Text] [Related]
6. The genetics of Parkinson's disease.
Mullin S; Schapira A
Br Med Bull; 2015 Jun; 114(1):39-52. PubMed ID: 25995343
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide estimates of heritability and genetic correlations in essential tremor.
Diez-Fairen M; Bandres-Ciga S; Houle G; Nalls MA; Girard SL; Dion PA; Blauwendraat C; Singleton AB; Rouleau GA; Pastor P
Parkinsonism Relat Disord; 2019 Jul; 64():262-267. PubMed ID: 31085086
[TBL] [Abstract][Full Text] [Related]
8. Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells.
Calatayud C; Carola G; Consiglio A; Raya A
Curr Opin Genet Dev; 2017 Oct; 46():123-131. PubMed ID: 28759872
[TBL] [Abstract][Full Text] [Related]
9. Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's Disease.
Koch S; Laabs BH; Kasten M; Vollstedt EJ; Becktepe J; Brüggemann N; Franke A; Krämer UM; Kuhlenbäumer G; Lieb W; Mollenhauer B; Neis M; Trenkwalder C; Schäffer E; Usnich T; Wittig M; Klein C; König IR; Lohmann K; Krawczak M; Caliebe A
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946808
[TBL] [Abstract][Full Text] [Related]
10. Mapping the Diverse and Inclusive Future of Parkinson's Disease Genetics and Its Widespread Impact.
Elsayed I; Martinez-Carrasco A; Cornejo-Olivas M; Bandres-Ciga S
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828286
[TBL] [Abstract][Full Text] [Related]
11. Genetics of Parkinson's disease.
Lill CM
Mol Cell Probes; 2016 Dec; 30(6):386-396. PubMed ID: 27818248
[TBL] [Abstract][Full Text] [Related]
12. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
[TBL] [Abstract][Full Text] [Related]
13. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.
Soldner F; Stelzer Y; Shivalila CS; Abraham BJ; Latourelle JC; Barrasa MI; Goldmann J; Myers RH; Young RA; Jaenisch R
Nature; 2016 May; 533(7601):95-9. PubMed ID: 27096366
[TBL] [Abstract][Full Text] [Related]
14. Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors.
Liu H; Dehestani M; Blauwendraat C; Makarious MB; Leonard H; Kim JJ; Schulte C; Noyce A; Jacobs BM; Foote I; Sharma M; ; Nalls M; Singleton A; Gasser T; Bandres-Ciga S
Ann Neurol; 2022 Aug; 92(2):270-278. PubMed ID: 35599344
[TBL] [Abstract][Full Text] [Related]
15. The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
Berge-Seidl V; Pihlstrøm L; Maple-Grødem J; Forsgren L; Linder J; Larsen JP; Tysnes OB; Toft M
Neurosci Lett; 2017 Sep; 658():48-52. PubMed ID: 28830825
[TBL] [Abstract][Full Text] [Related]
16. Genetic Risk Profiling in Parkinson's Disease and Utilizing Genetics to Gain Insight into Disease-Related Biological Pathways.
Hall A; Bandres-Ciga S; Diez-Fairen M; Quinn JP; Billingsley KJ
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33020390
[TBL] [Abstract][Full Text] [Related]
17. What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?
Fernández-Santiago R; Sharma M
Ageing Res Rev; 2022 Aug; 79():101648. PubMed ID: 35595184
[TBL] [Abstract][Full Text] [Related]
18. Identifying Risk Genes and Interpreting Pathogenesis for Parkinson's Disease by a Multiomics Analysis.
Cheng WW; Zhu Q; Zhang HY
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32967142
[TBL] [Abstract][Full Text] [Related]
19. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
20. The genetic architecture of Parkinson's disease.
Blauwendraat C; Nalls MA; Singleton AB
Lancet Neurol; 2020 Feb; 19(2):170-178. PubMed ID: 31521533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
